Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 6, 2020

 

 

 

LOGO

NN, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-23486   62-1096725

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

6210 Ardrey Kell Road

Charlotte, North Carolina

  28277
(Address of principal executive offices)   (Zip Code)

(980) 264-4300

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

symbol

  

Name of each exchange

on which registered

Common Stock, par value $0.01    NNBR    The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company.  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


ITEM 2.02.

RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On August 6, 2020, NN, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended June 30, 2020. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

Pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”), the information furnished pursuant to Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is deemed to have been furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

ITEM 9.01.

FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

 

Exhibit No.

  

Description

99.1    Press Release issued by NN, Inc., dated August 6, 2020


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 6, 2020

 

NN, INC.
By:  

/s/ Matthew S. Heiter

Name:   Matthew S. Heiter
Title:   Senior Vice President, General Counsel
EX-99.1

Exhibit 99.1

 

LOGO

 

LOGO

RE: NN, Inc.

6210 Ardrey Kell Road

Charlotte, NC 28277

FOR FURTHER INFORMATION:

AT ABERNATHY MACGREGOR

Claire Walsh    

(General info)    

(212) 371-5999    

FOR IMMEDIATE RELEASE

August 6, 2020

NN, INC. REPORTS SECOND QUARTER 2020 RESULTS

Free cash flow improved by $9.1 million compared to prior year

Amended debt agreement enhances financial flexibility

Charlotte, N.C., August 6, 2020 – NN, Inc., (NASDAQ: NNBR), a diversified industrial company, today reported its financial results for the second quarter ended June 30, 2020.

GAAP Results

Net sales for the second quarter of 2020 decreased $71.2 million, or 32.1%, to $150.4 million, compared to $221.7 million for the second quarter of 2019, driven by a decline in organic volume of $69.9 million, as a result of lower demand due to the COVID-19 pandemic within the orthopaedic, global automotive, electrical products, and oil and gas end markets, along with unfavorable foreign exchange effects of $1.3 million.

On a GAAP basis, loss from operations for the second quarter of 2020 was $8.2 million, compared to income from operations of $7.5 million for the same period in 2019. In the second quarter of 2020, the loss from operations was primarily driven by the above-referenced sales volume decline, which was partially offset by cost reduction initiatives that resulted in lower personnel and travel costs.

Net loss on a GAAP basis for the second quarter of 2020 was $21.7 million, compared to net loss on a GAAP basis of $7.3 million in the second quarter of 2019.

On a GAAP basis, income from operations for second quarter 2020 in the Life Sciences segment was $4.3 million, compared to income from operations of $9.3 million for the same period in 2019.

On a GAAP basis, loss from operations for second quarter 2020 in the Mobile Solutions segment was $4.6 million, compared to income from operations of $3.5 million for the same period in 2019.

 

1


On a GAAP basis, income from operations for second quarter 2020 in the Power Solutions segment was $1.5 million, compared to income from operations of $5.7 million for the same period in 2019.

Adjusted Results

Adjusted income from operations for the second quarter of 2020 was $8.0 million, compared to $27.3 million for the same period in 2019. Adjusted EBITDA for the second quarter of 2020 was $22.9 million, or 15.3% of sales, versus $39.3 million, or 17.7% of sales, for the same period in 2019. Adjusted net loss was $4.8 million, or $0.11 per diluted share, compared to adjusted net income of $10.0 million, or $0.24 per diluted share, for the same period in 2019. Free cash flow improved significantly by $9.1 million and net debt decreased by $94.3 million when compared to the same period in 2019.

Warren Veltman, President and Chief Executive Officer, said, “As expected, our second quarter was significantly impacted across the globe due to the COVID-19 pandemic. In light of these unprecedented challenges, we ramped up cost savings measures that were initially implemented in the fall to best align our cost structure to the current environment and preserve cash. These initiatives along with reductions in working capital have resulted in increased cash flow of $9.1 million year over year and positive cash flow year to date. We also recently amended our credit facility and obtained covenant relief for the second and third quarter, which provides us with near-term enhanced financial flexibility to manage through the impact of the pandemic through the end of the year. As we move into the second half of the year, we will continue to be disciplined in managing our working capital and look for additional ways to save costs and improve our liquidity.”

Mr. Veltman continued: “I am proud of our team for their outstanding efforts in the face of enormous challenges. Our top priorities for the second quarter were to keep our employees safe and satisfy all our customer requirements, and we accomplished this through implementing increased cleaning and safety practices in our facilities. The health and safety of our employees will continue to be our priority as we navigate the COVID-19 pandemic in the second half of the year.”

Life Sciences

Net sales for the second quarter of 2020 were $72.4 million, compared to $91.3 million in the second quarter of 2019, a decrease of 20.7% or $18.9 million. Adjusted income from operations for the second quarter of 2020 was $13.9 million, compared to $20.4 million in the second quarter of 2019. Lost variable margin on lower sales and higher depreciation expense attributable to the capital investments made during 2019 to support expected business growth contributed to the decrease in adjusted income from operations. These unfavorable impacts were partially offset by savings from continuous improvement initiatives and overall reductions in manufacturing and SG&A costs resulting from significant cost savings initiatives implemented to respond to the unfavorable impacts of the COVID-19 pandemic.

Mobile Solutions

Net sales for the second quarter of 2020 were $41.0 million, compared to $79.4 million in the second quarter of 2019, a decrease of 48.3% or $38.4 million. Adjusted loss from operations for the second quarter of 2020 was $3.4 million, compared to $5.6 million of adjusted operating income in the second quarter of 2019. The reduction in adjusted operating income was due to lost variable margin on the sales volume decline, which was partially offset by fixed cost reduction actions taken in response to the decline in sales volume.

 

2


Power Solutions

Net sales for the second quarter of 2020 were $37.5 million, compared to $51.4 million in the second quarter of 2019, a decrease of $13.9 million or 27.0%. Adjusted income from operations for the quarter was $4.7 million, compared to $10.1 million in the second quarter of 2019. The reduction in adjusted operating income was due to lost variable margin on the sales volume decline, which was partially offset by fixed cost reduction actions taken in response to the decline in sales volume.

Conference Call

NN will discuss its results during its quarterly investor conference call on August 7, 2020 at 9:00 a.m. ET. The call and supplemental presentation may be accessed via NN’s website, www.nninc.com. The conference call can also be accessed by dialing 1-888-220-8474 or 1-323-794-2591 Conference ID: 7729601. For those who are unavailable to listen to the live broadcast, a replay will be available shortly after the call for 30 days.

NN discloses in this press release the non-GAAP financial measures of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share, free cash flow and net debt. Each of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share and free cash flow provides supplementary information about the impacts of restructuring and integration expense, acquisition and transition expenses, foreign exchange impacts on inter-company loans, amortization of intangibles and deferred financing costs, and other non-operating impacts on our business. Net debt is defined as debt and finance leases less cash.

The financial tables found later in this press release include a reconciliation of adjusted income from operations, adjusted operating margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), adjusted net income (loss) per diluted share and free cash flow to the U.S. GAAP financial measures of income from operations, net income (loss), net income (loss) per diluted share and net cash provided by (used in) operating activities.

About NN, Inc.

NN, Inc., a diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has 48 facilities in North America, Europe, South America, and China.

Except for specific historical information, many of the matters discussed in this press release may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are forward-looking statements concerning matters that involve risks, uncertainties and other factors which may cause the actual performance of NN, Inc. and its subsidiaries to differ materially from those expressed or implied by this discussion. All forward-looking information is provided by the Company pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “assumptions”, “target”, “guidance”, “outlook”, “plans”, “projection”, “may”, “will”, “would”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “potential” or “continue” (or the negative or other derivatives of each of these terms) or similar terminology. Factors which could materially affect actual results include, but are not limited to: general economic conditions and economic conditions in the industrial sector, the impacts of the coronavirus (COVID-19) pandemic on the Company’s financial condition, business operations and liquidity, inventory levels, regulatory compliance costs and the Company’s ability to manage these costs, start-up costs for new operations, debt reduction, competitive influences, risks that current customers will commence or increase captive production, risks of capacity underutilization, quality issues, availability and price of raw materials, currency and other risks associated with international trade, the Company’s dependence on certain major customers, and the successful implementation of the global growth plan including development of new products. Similarly, statements made herein and elsewhere regarding pending and completed transactions are also forward-looking statements, including statements relating to the future performance and prospects of an acquired business, the expected benefits of an acquisition on the Company’s future business and operations and the ability of the Company to successfully integrate recently acquired businesses.

 

3


For additional information concerning such risk factors and cautionary statements, please see the section titled “Risk Factors” in the Company’s periodic reports filed with the Securities and Exchange Commission, including, but not limited to, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and when filed, the Company’s Quarterly Report on Form 10-Q for the three months ended June 30, 2020. Except as required by law, we undertake no obligation to update or revise any forward-looking statements we make in our press releases, whether as a result of new information, future events or otherwise.

Financial Tables Follow

NN, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(Unaudited)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
(in thousands, except per share data)    2020     2019     2020     2019  

Net sales

   $ 150,420     $ 221,666     $ 350,165     $ 434,922  

Cost of sales (exclusive of depreciation and amortization shown separately below)

     115,389       164,099       267,630       326,286  

Selling, general and administrative expense

     20,991       26,743       45,815       54,868  

Depreciation and amortization

     23,201       22,924       46,385       46,349  

Restructuring and integration expense, net

     —         —         —         (12

Goodwill impairment

     —         —         239,699       —    

Other operating (income) expense, net

     (955     388       4,174       236  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations

     (8,206     7,512       (253,538     7,195  

Interest expense

     18,696       13,958       35,773       27,759  

Loss on extinguishment of debt and write-off of debt issuance costs

     —         —         —         2,699  

Other (income) expense, net

     (881     57       239       786  
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before benefit (provision) for income taxes and share of net income (loss) from joint venture

     (26,021     (6,503     (289,550     (24,049

Benefit (provision) for income taxes

     3,346       (577     18,955       (2,818

Share of net income (loss) from joint venture

     927       (203     656       66  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (21,748   $ (7,283   $ (269,939   $ (26,801
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive gain (loss):

        

Foreign currency translation gain (loss)

     994       (1,497     (13,348     (176

Interest rate swap:

        

Change in fair value of interest rate swap, net of tax

     (1,255     (6,962     (12,464     (10,818

Less: reclassification adjustment for losses included in net loss, net of tax

     2,638       —         3,690       —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss)

   $ 2,377     $ (8,459   $ (22,122   $ (10,994
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (19,371   $ (15,742   $ (292,061   $ (37,795
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic net loss per common share:

        

Net loss per common share

   $ (0.59   $ (0.17   $ (6.55   $ (0.64
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average common shares outstanding

     42,197       42,028       42,154       42,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted net loss per common share:

        

Net loss per common share

   $ (0.59   $ (0.17   $ (6.55   $ (0.64
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average common shares outstanding

     42,197       42,028       42,154       42,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

4


NN, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

(in thousands)    June 30,
2020
    December 31,
2019
 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 82,695     $ 31,703  

Accounts receivable, net

     105,661       131,558  

Inventories

     121,031       118,722  

Income tax receivable

     17,458       5,973  

Other current assets

     15,477       15,024  
  

 

 

   

 

 

 

Total current assets

     342,322       302,980  

Property, plant and equipment, net

     344,073       374,513  

Operating lease right-of-use assets

     77,121       65,496  

Goodwill

     196,467       439,095  

Intangible assets, net

     306,577       329,260  

Investment in joint venture

     22,104       21,755  

Other non-current assets

     7,350       8,885  
  

 

 

   

 

 

 

Total assets

   $ 1,296,014     $ 1,541,984  
  

 

 

   

 

 

 

Liabilities, Preferred Stock, and Stockholders’ Equity

    

Current liabilities:

    

Accounts payable

   $ 43,751     $ 57,340  

Accrued salaries, wages and benefits

     33,335       30,428  

Income tax payable

     867       1,028  

Current maturities of long-term debt

     20,567       19,160  

Current portion of operating lease liabilities

     7,068       6,652  

Other current liabilities

     32,266       24,873  
  

 

 

   

 

 

 

Total current liabilities

     137,854       139,481  

Deferred tax liabilities

     73,691       85,799  

Non-current income tax payable

     —         1,272  

Long-term debt, net of current portion

     816,956       757,440  

Operating lease liabilities, net of current portion

     79,712       66,980  

Other non-current liabilities

     31,195       44,723  
  

 

 

   

 

 

 

Total liabilities

     1,139,408       1,095,695  

Commitments and contingencies

    

Series B convertible preferred stock - $0.01 par value per share, 100 shares authorized, 100 shares issued and outstanding at December 31, 2019, and June 30, 2020

     98,707       93,012  

Stockholders’ equity:

    

Common stock - $0.01 par value per share, 90,000 shares authorized, 42,313 and 42,747 shares issued and outstanding at December 31, 2019, and June 30, 2020, respectively

     427       423  

Additional paid-in capital

     498,294       501,615  

Warrants

     1,076       1,076  

Accumulated deficit

     (375,222     (105,283

Accumulated other comprehensive loss

     (66,676     (44,554
  

 

 

   

 

 

 

Total stockholders’ equity

     57,899       353,277  
  

 

 

   

 

 

 

Total liabilities, preferred stock, and stockholders’ equity

   $ 1,296,014     $ 1,541,984  
  

 

 

   

 

 

 

 

5


NN, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

     Six Months Ended
June 30,
 
(in thousands)    2020     2019  

Cash flows from operating activities

    

Net loss

   $ (269,939   $ (26,801

Adjustments to reconcile net loss to net cash provided by operating activities:

    

Depreciation and amortization

     46,385       46,349  

Amortization of debt issuance costs

     3,348       2,354  

Goodwill impairment

     239,699       —    

Loss on extinguishment of debt and write-off of debt issuance costs

     —         2,699  

Share of net income from joint venture, net of cash dividends received

     (656     (66

Compensation expense from issuance of share-based awards

     2,707       1,979  

Deferred income taxes

     (8,889     (8,093

Other

     (2,207     540  

Changes in operating assets and liabilities:

    

Accounts receivable

     23,485       (17,723

Inventories

     (4,327     (4,839

Accounts payable

     (12,391     (1,405

Income taxes receivable and payable, net

     (12,897     1,646  

Other

     11,544       7,727  
  

 

 

   

 

 

 

Net cash provided by operating activities

     15,862       4,367  

Cash flows from investing activities

    

Acquisition of property, plant and equipment

     (15,624     (28,994

Proceeds from liquidation of short-term investment

     —         8,000  

Proceeds from sale of property, plant, and equipment

     3,112       1,949  

Other

     —         (726
  

 

 

   

 

 

 

Net cash used in investing activities

     (12,512     (19,771

Cash flows from financing activities

    

Cash paid for debt issuance or prepayment costs

     (286     (967

Dividends paid

     —         (5,913

Proceeds from long-term debt

     64,716       46,630  

Repayment of long-term debt

     (9,078     (12,055

Proceeds from (repayments of) short-term debt, net

     (411     (6,218

Other

     (1,523     (1,759
  

 

 

   

 

 

 

Net cash provided by financing activities

     53,418       19,718  

Effect of exchange rate changes on cash flows

     (5,776     (225

Net change in cash and cash equivalents

     50,992       4,089  

Cash and cash equivalents at beginning of period

     31,703       17,988  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 82,695     $ 22,077  
  

 

 

   

 

 

 

 

6


Reconciliation of GAAP Income from Operations to Non-GAAP Adjusted Income from Operations

 

     Three Months Ended  
$000s    June 30,  
NN, Inc. Consolidated    2020     2019  

GAAP income from operations

   $ (8,206   $ 7,512  

Acquisition and transition expense*

     4,843       7,546  

Amortization of intangibles

     11,341       11,811  

Impairments (Goodwill and fixed assets)

     —         400  
  

 

 

   

 

 

 

Non-GAAP adjusted income from operations (a)

   $ 7,977     $ 27,268  
  

 

 

   

 

 

 

Non-GAAP adjusted operating margin (1)

     5.3     12.3

GAAP net sales

   $ 150,420     $ 221,666  

 

     Three Months Ended  
$000s    June 30,  
Mobile Solutions    2020     2019  

GAAP income from operations

   $ (4,592   $ 3,506  

Acquisition and transition expense

     344       1,240  

Amortization of intangibles

     838       886  

Impairments (Goodwill and fixed assets)

     —         —    
  

 

 

   

 

 

 

Non-GAAP adjusted income from operations (a)

   $ (3,410   $ 5,632  
  

 

 

   

 

 

 

Share of net income from joint venture

     926       (203
  

 

 

   

 

 

 

Non-GAAP adjusted income from operations with JV

     (2,483     5,429  
  

 

 

   

 

 

 

Non-GAAP adjusted operating margin (1)

     -6.1     6.8

GAAP net sales

   $ 41,037     $ 79,444  

 

     Three Months Ended  
$000s    June 30,  
Elimination    2020     2019  

GAAP net sales

   $ (507   $ (503
     Three Months Ended  
$000s    June 30,  
Power Solutions    2020     2019  

GAAP income from operations

   $ 1,454     $ 5,682  

Acquisition and transition expense

     507       1,640  

Amortization of intangibles

     2,748       2,749  

Impairments (Goodwill and fixed assets)

     —         —    
  

 

 

   

 

 

 

Non-GAAP adjusted income from operations (a)

   $ 4,709     $ 10,071  
  

 

 

   

 

 

 

Non-GAAP adjusted operating margin (1)

     12.6     19.6

GAAP net sales

   $ 37,491     $ 51,393  

 

     Three Months Ended  
$000s    June 30,  
Life Sciences    2020     2019  

GAAP income from operations

   $ 4,333     $ 9,305  

Acquisition and transition expense

     1,823       2,937  

Amortization of intangibles

     7,754       8,176  

Impairments (Goodwill and fixed assets)

     —         —    
  

 

 

   

 

 

 

Non-GAAP adjusted income from operations (a)

   $ 13,910     $ 20,418  
  

 

 

   

 

 

 

Non-GAAP adjusted operating margin (1)

     19.2     22.4

GAAP net sales

   $ 72,399     $ 91,332  

 

 

 

(1)

Non-GAAP adjusted operating margin = Non-GAAP adjusted income from operations/ GAAP net sales

*

2020 Includes Capacity & Capabilities Dev—$0.7 / Prof Fees—$2.0 / Integration & Transformation—$3.0 / Acq Transaction Costs—$0.0 / Asset Write-Downs/Inventory Step-Up—($0.9)

*

2019 Includes Capacity & Capabilities Dev—$2.4 / Prof Fees—$0.1 / Integration & Transformation—$5.0 / Acq Transaction Costs—$0.0 / Asset Write-Downs/Inventory Step-Up—$0.0

 

7


Reconciliation of Net Income (Loss) to Non-GAAP Adjusted EBITDA

 

     Three Months Ended  
     June 30,  
$000s    2020     2019  

GAAP net income (loss)

   $ (21,748   $ (7,283

Provision (benefit) for income taxes

     (3,346     577  

Interest expense

     18,696       13,958  

Change in fair value of preferred stock tax withholding

     (31     —    

Depreciation and amortization

     23,201       22,924  

Acquisition and transition expense

     4,843       7,364  

Non-cash stock compensation

     1,412       1,106  

Non-cash foreign exchange (gain) loss on inter-company loans

     (79     (454

Costs related to divested businesses

     —         700  

Impairments (Goodwill, JV and fixed assets)

     —         400  
  

 

 

   

 

 

 

Non-GAAP adjusted EBITDA (b)

   $ 22,947     $ 39,292  
  

 

 

   

 

 

 

Non-GAAP adjusted EBITDA margin (2)

     15.3     17.7

GAAP net sales

   $ 150,420     $ 221,666  

 

(2)

Non-GAAP adjusted EBITDA margin = Non-GAAP adjusted EBITDA / GAAP net sales

 

8


Reconciliation of Net Income (Loss) to Non-GAAP Adjusted Net Income (Loss) and Net Income (Loss) per Diluted Share to Non-GAAP Adjusted Net Income (Loss) per Diluted Share

 

     Three Months Ended  
     June 30,  
$000s    2020      2019  

GAAP net income (loss)

   $ (21,748    $ (7,283

Pre-tax acquisition and transition expense

     4,843        7,546  

Pre-tax foreign exchange (gain) loss on inter-company loans

     (79      (454

Pre-tax change in fair value of preferred stock tax withholding

     (31      —    

Pre-tax amortization of intangibles and deferred financing costs

     13,039        12,973  

Pre-tax impairments of fixed asset costs

     —          400  

Pre-tax costs related to divested businesses

     —          700  

Tax effect of adjustments reflected above (c)

     (3,732      (3,839

Non-GAAP discrete tax adjustments

     2,864        —    
  

 

 

    

 

 

 

Non-GAAP adjusted net income (loss) (d)

   $ (4,845    $ 10,043  
  

 

 

    

 

 

 
     Three Months Ended  
     June 30,  
Amounts per share, diluted    2020      2019  

GAAP net income (loss) per diluted share

   $ (0.59    $ (0.17

Pre-tax acquisition and transition expense

     0.11        0.18  

Pre-tax foreign exchange (gain) loss on inter-company loans

     (0.00      (0.01

Pre-tax change in fair value of preferred stock tax withholding

     (0.00      —    

Pre-tax amortization of intangibles and deferred financing costs

     0.31        0.31  

Pre-tax impairments of fixed asset costs

     —          0.01  

Pre-tax costs related to divested businesses

     —          0.02  

Tax effect of adjustments reflected above (c)

     (0.09      (0.09

Non-GAAP discrete tax adjustments

     0.07        —    

Preferred stock cumulative dividends and deemed dividends

     0.07        —    
  

 

 

    

 

 

 

Non-GAAP adjusted net income (loss) per diluted share (d)

   $ (0.11    $ 0.24  
  

 

 

    

 

 

 

Weighted average shares outstanding, diluted

     42,197        42,028  

 

9


Reconciliation of Operating Cash Flow to Free Cash Flow

 

     Three Months Ended  
     June 30,  
$000s    2020     2019  

Net cash provided (used) by operating activities

   $ 5,638     $ 7,079  

Acquisition of property, plant and equipment

     (4,364     (14,921
  

 

 

   

 

 

 

Free Cash Flow

   $ 1,274     $ (7,842
  

 

 

   

 

 

 

Reconciliation of Net Debt

 

     June 30,      June 30,  
$000s    2020      2019  

Short term debt & finance lease liability

   $ 24,178      $ 27,446  

Long term debt and finance lease liability (ex- issuance costs)

     826,368        856,753  
  

 

 

    

 

 

 

Funded debt

     850,546        884,199  

Cash and cash equivalents

     82,695        22,077  
  

 

 

    

 

 

 

Net debt

   $ 767,851      $ 862,122  
  

 

 

    

 

 

 

The Company discloses in this presentation the non-GAAP financial measures of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share, free cash flow and net debt. Each of these non-GAAP financial measures provides supplementary information about the impacts of acquisition, divestiture and integration related expenses, foreign-exchange impacts on inter-company loans, reorganizational and impairment charges. Over the past five years, we have completed seven acquisitions, two of which were transformative for the Company, and sold two of our businesses. The costs we incurred in completing such acquisitions, including the amortization of intangibles and deferred financing costs, and these divestitures have been excluded from these measures because their size and inconsistent frequency are unrelated to our commercial performance during the period, and which we believe are not indicative of our ongoing operating costs. We exclude the impact of currency translation from these measures because foreign exchange rates are not under management’s control and are subject to volatility. Other non-operating charges are excluded as the charges are not indicative of our ongoing operating cost. We believe the presentation of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share, free cash flow and net debt provides useful information in assessing our underlying business trends and facilitates comparison of our long-term performance over given periods.

The non-GAAP financial measures provided herein may not provide information that is directly comparable to that provided by other companies in the Company’s industry, as other companies may calculate such financial results differently. The Company’s non-GAAP financial measures are not measurements of financial performance under GAAP and should not be considered as alternatives to actual income growth derived from income amounts presented in accordance with GAAP. The Company does not consider these non-GAAP financial measures to be a substitute for, or superior to, the information provided by GAAP financial results.

(a) Non-GAAP adjusted income from operations represents GAAP income from operations, adjusted to exclude the effects of restructuring and integration expense; non-operational charges related to acquisition and transition expense, intangible amortization costs for fair value step-up in values related to acquisitions, non-cash impairment charges, and when applicable, our share of income from joint venture operations. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted income from operations is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income from operations.

(b) Non-GAAP adjusted EBITDA represents GAAP net income (loss), adjusted to include income taxes, interest expense, Interest rate swaps and write-offs, depreciation and amortization, charges related to acquisition and transition costs, non-cash stock compensation expense, foreign exchange gain (loss) on inter-company loans, restructuring and integration expense, income from discontinued operations, and non-cash impairment charges, to the extent applicable. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income (loss) from continuing operations.

 

10


(c) This line item reflects the aggregate tax effect of all nontax adjustments reflected in the respective table. NN, Inc. estimates the tax effect of the adjustment items identified in the reconciliation schedule above by applying the applicable statutory rates by tax jurisdiction unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment.

(d) Non-GAAP adjusted net income (loss) represents GAAP net income (loss) adjusted to exclude the tax-affected effects of restructuring and integration charges (related to plant closures and other charges incurred to implement our strategic goals that do not necessarily represent a major strategic shift in operations), charges related to acquisition and transition costs, amortization of intangibles costs for fair value step-up in values related to acquisitions and amortization of deferred financing costs, foreign exchange gain (loss) on inter-company loans, estimated interest expense on cash held from divestiture, non-cash impairment charges, the impact of enactment of the Tax Cut and Jobs Act and income from discontinued operations. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted income (loss) from segment operations is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income (loss) from continuing operations.

 

11